Malaria in Pregnancy, Prevention (Green-top Guideline No. 54A)

Published:

This guideline provides clinicians with evidence-based information about the prevention of malaria in pregnancy in situations likely to be encountered in UK clinical practice (i.e. in UK residents visting malaria endemic areas).

This is the first edition of this guideline.

Update February 2017: Following a review of all guidelines in December 2016, some minor editorial changes have been made to this guideline since the original publication. The version available here is the most up to date. The date on the guideline has not been changed since no amendments were made to the content.

Update December 2014: New evidence and guidance in this field were reviewed in 2014 and it was decided that revision of this guideline would be deferred to a later date. The version available on the website and app will remain valid until replaced.

The aim of this guideline is to provide clinicians with evidence-based, up-to-date information about the prevention of malaria in pregnancy in situations that are likely to be encountered in UK medical facilities (that is, UK-based residents visiting malaria endemic areas). These guidelines are not necessarily appropriate for those residing in endemic areas.

This guideline covers malaria prevention travel recommendations in:

Women planning a pregnancy
Those already pregnant or breast feeding

Please note that drug recommendations for malaria prophylaxis can change owing to resistance. Up-to-date information on drugs can be obtained using online resources as described in this guideline.

Information about the diagnosis and treatment of malaria in pregnancy can be found in Green-top Guideline No. 54b: Diagnosis and treatment of malaria in pregnancy.